Clinical Experimental Randomized Study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane And Estramustine-17-phosphate In The Treatment Of Prostatic Carcinoma-Reference-Cited by-同舟云学术

Clinical Experimental Randomized Study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane And Estramustine-17-phosphate In The Treatment Of Prostatic Carcinoma

Published:1978-12 Issue:6 Volume:120 Page:705-707
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Edsmyr Folke¹,Esposti Pier-Luigi¹,Johansson Bengt¹,Strindberg Bengt¹

Affiliation:

1. From Radiumhemmet and the Department of Urology, Karolinska Hospital and AB KABI, Stockholm, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference3 articles.

1. Forty days oral toxicity of 2,6-cis-diphenylhexamethylcyclote-trasiloxane (KABI 1774) in beagle dogs with special reference to effects on the male reproductive system;Albanus;Acta Pharm. Tox.,1975

2. Pharmacokinetics of 2,6-cis-diphenylhexamethylcyclotetrasiloxane in man;Pilbrant;Acta Pharm. Tox.,1975

3. Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-diphenylhexamethylcyclote-trasiloxane or estramustine-17-phosphate;Blombäck;Urol. Res.,1978

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy options in castration-resistant prostate cancer;Indian Journal of Urology;2016

2. Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis;Canadian Medical Association Journal;2014-09-29

3. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate;Cochrane Database of Systematic Reviews;2008-07-16

4. Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate;Cochrane Database of Systematic Reviews;2007-04-18

5. Chemotherapy for hormone-refractory prostate cancer;Cochrane Database of Systematic Reviews;2006-10-18